adamantane has been researched along with Liver Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dey, P; Katzenellenbogen, BS; Katzenellenbogen, JA; Kim, SH; Laws, MJ; Nelson, ER; Nettles, KW; Park, BH; Shahoei, SH; Yasuda, M; Ziegler, Y | 1 |
| Abd Elhameed, AG; Helal, MG; Said, E; Salem, HA | 1 |
| Fang, F; Huang, Y; Li, W; Liao, Q; Liao, X; Liu, X; Long, M; Ouyang, Q; Rojo de la Vega, M; Tang, Z; Tong, Q; Wang, H; Wang, X; Wang, Y; Yu, S; Zhang, DD; Zhang, L; Zhang, R; Zheng, H; Zheng, Y | 1 |
| Aerts, JM; Bijl, N; Boot, RG; Groen, AK; Ottenhoff, R; Scheij, S; Sokolovic, M; Triantis, V; van Eijk, M; van Roomen, CP | 1 |
| Beljanski, V; Lewis, CS; Smith, CD | 1 |
| Amirkhosravi, A; Arlt, MJ; Banke, IJ; Krüger, A; Moroder, L; Mueller, MM; Sperl, S; Stemberger, A; Stürzebecher, J | 1 |
6 other study(ies) available for adamantane and Liver Neoplasms
| Article | Year |
|---|---|
Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors.
Topics: Adamantane; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Estrogen Receptor Modulators; Female; Humans; Ketones; Liver Neoplasms; MCF-7 Cells; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Receptors, Estrogen; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
Saxagliptin defers thioacetamide-induced hepatocarcinogenesis in rats: A novel suppressive impact on Wnt/Hedgehog/Notch1 signaling.
Topics: Adamantane; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Hedgehog Proteins; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Rats, Sprague-Dawley; Receptor, Notch1; Thioacetamide; Wnt Signaling Pathway | 2021 |
NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis.
Topics: Adamantane; Animals; Antioxidants; Biomarkers, Tumor; Cell Line, Tumor; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Glutamate-Cysteine Ligase; Humans; Hypoglycemic Agents; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; Mice; Neoplasm Metastasis; NF-E2-Related Factor 2; Risk Factors; Signal Transduction; Sitagliptin Phosphate; Thioctic Acid; Ubiquitination | 2016 |
Reduction of glycosphingolipid biosynthesis stimulates biliary lipid secretion in mice.
Topics: 1-Deoxynojirimycin; Adamantane; Animals; Bile; Cell Line, Tumor; Cells, Cultured; Cholesterol; Cholesterol, HDL; Gallbladder; Gangliosides; Glycosphingolipids; Humans; Lipid Metabolism; Lipoproteins, HDL; Liver Neoplasms; Mice; Mice, Inbred C57BL; RNA, Messenger; Signal Transduction; Triglycerides | 2009 |
Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts.
Topics: Adamantane; Animals; Antineoplastic Agents; Apoptosis; Benzenesulfonates; Blotting, Western; Carcinoma, Hepatocellular; Flow Cytometry; Hep G2 Cells; Humans; Liver Neoplasms; Lysophospholipids; Mice; Mitogen-Activated Protein Kinases; Niacinamide; Phenylurea Compounds; Phosphotransferases (Alcohol Group Acceptor); Pyridines; Sorafenib; Sphingosine; Xenograft Model Antitumor Assays | 2011 |
Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity.
Topics: Adamantane; Animals; Anticoagulants; Antineoplastic Agents; Factor Xa; Factor Xa Inhibitors; Female; Fibrosarcoma; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, T-Cell; Mice; Mice, Inbred DBA; Naphthalenes; Propionates; Serine Proteinase Inhibitors; Specific Pathogen-Free Organisms; Whole Blood Coagulation Time | 2005 |